Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-36
Closed -$1.09K 924
2023
Q2
$1.09K Buy
36
+2
+6% +$58 ﹤0.01% 855
2023
Q1
$1.05K Sell
34
-7
-17% -$267 ﹤0.01% 893
2022
Q4
$1.54K Buy
41
+6
+17% +$238 ﹤0.01% 846
2022
Q3
$1K Sell
35
-1
-3% -$40 ﹤0.01% 898
2022
Q2
$1K Sell
36
-1
-3% -$41 ﹤0.01% 900
2022
Q1
$2K Sell
37
-1
-3% -$51 ﹤0.01% 848
2021
Q4
$2K Sell
38
-6
-14% -$284 ﹤0.01% 857
2021
Q3
$2K Hold
44
﹤0.01% 980
2021
Q2
$2K Sell
44
-2
-4% -$94 ﹤0.01% 963
2021
Q1
$2K Sell
46
-9
-16% -$377 ﹤0.01% 921
2020
Q4
$2K Sell
55
-14
-20% -$405 ﹤0.01% 898
2020
Q3
$1K Hold
69
﹤0.01% 952
2020
Q2
$1K Buy
69
+2
+3% +$39 ﹤0.01% 844
2020
Q1
$1K Buy
+67
New +$2.06K ﹤0.01% 918
2018
Q3
Sell
-23
Closed -$1K 716
2018
Q2
$1K Buy
+23
New +$1.22K ﹤0.01% 905

Other funds holding SNV

Washington Trust's SNV Position: Q3 2023 in Review

Washington Trust sold out of Synovus (SNV) in Q3 2023, closing a stake of 36 shares — an estimated $1.09K sold.

Washington Trust first reported a position in SNV in Q2 2018 and held it in 15 quarters. The position peaked at $2K in Q1 2022. 371 funds tracked by Wall St. Rank hold SNV as of Q3 2023.

  • Washington Trust reported no remaining Synovus position as of Q3 2023 after selling out during the quarter.
  • Washington Trust sold 36 Synovus shares in Q3 2023, an estimated $1.09K.
  • Washington Trust first reported a position in Synovus in Q2 2018 and held it in 15 quarters.
  • Washington Trust's Synovus position peaked at $2K in Q1 2022.
  • 371 funds tracked by Wall St. Rank held Synovus as of Q3 2023.

Based on Washington Trust's 13F filing for Q3 2023, filed 18 Oct 2023.